Skip to main content
. 2018 Nov 30;24:8655–8668. doi: 10.12659/MSM.911125

Figure 4.

Figure 4

Gemcitabine/cisplatin resistance for squamous cell carcinoma. ROC curve analysis was used to access the optimal cutoff values for gemcitabine/cisplatin resistance for age, PLT, MPV, PCT, PDW, and CA125. ROC – receiver operating characteristic; PLC – platelet count; MPV – mean platelet volume; PCT – plateletcrit, PDW – platelet distribution width; CA125 – cancer antigen 125.